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This	is	a	response	to	an	essay	by	J-F	Etter	published	in	Addiction	in	2017	(see	reference	#1).	It	
was	sent	to	Addiction	which	offered	a	500	word	letter.	The	full	response	is	posted	here)	
	
Etter’s	valuable	contribution	[1]	to	the	debate	on	the	plausibility	of	gateway	effects	as	they	
might	apply	to	e-cigarettes	is	most	welcome.	He	makes	many	salient	points	that	
comprehensively	circumscribe	key	points	of	the	debate.	However,	there	are	several	key	
issues	that	we	believe	he	has	not	addressed	satisfactorily.	
	
Lack	of	coherence	with	population	data	on	teenage	smoking?	
	
Etter	repeats	a	frequently	made	argument	that	the	gateway	hypothesis	is	incompatible	with	
evidence	from	the	USA	[2]	and	UK	[3]	of	declining	adolescent	smoking.	The	argument	here	
runs	that	vaping	has	been	rising	while	smoking	continues	to	fall,	so	vaping	cannot	be	
causing	smoking	to	any	significant	degree	at	the	adolescent	population	level.[4]		
	
This	argument	relies	on	an	assumption	that	the	population-wide	net	impact	of	any	putative	
gateway	effect	of	e-cigarette	use	would	be	larger	than	the	combined	net	impact	of	all	other	
policies,	programs	and	factors	which	are	responsible	for	reducing	adolescent	smoking	
prevalence	(for	example,	tobacco	tax	and	retail	price	[5],	measures	of	the	denormalisation	
of	smoking[6],	exposure	of	children	to	adult-targeted	quit	campaigns[7],	retail	display	bans	
[8],	health	warnings	[9]	and	plain	packaging[10]).	This	is	a	ridiculously	high	bar	that	gateway	
critics	demand	that	anyone	suggesting	gateway	effects	must	jump	over.		
	
It	is	clearly	possible	that	significant	numbers	of	vaping	teenagers	who	might	otherwise	not	
have	smoked	could	take	up	smoking	in	an	environment	where	there	was	a	larger	preventive	
effect	occurring	in	response	to	comprehensive	efforts	to	reduce	smoking	uptake.	The	
combined	impact	of	such	factors	in	preventing	uptake	could	thereby	easily	mask	
considerable	smoking	uptake	that	might	have	not	occurred	in	the	absence	of	e-cigarettes.	
	
With	smoking	prevalence	at	record	lows	in	both	the	US	and	England,	only	longitudinal	
studies	with	very	large	numbers	of	participants	would	have	the	statistical	power	to	consider	
with	any	confidence	the	factors	responsible	for	changes	in	the	absolute	proportions	of	
adolescents	who	smoked.	Cross-sectional	studies	could	never	be	definitive.	
	
For	this	reason,	longitudinal	prospective	cohorts	which	control	for	factors	known	to	be	
associated	with	smoking	uptake	are	vital	to	examining	potential	gateway	effects.	Nine	of	
these	have	recently	been	included	in	a	meta-analysis	[11].	Adjusting	for	demographic,	
psychosocial,	and	behavioural	risk	factors	for	cigarette	smoking,	the	odds	of	subsequent	
cigarette	smoking	by	non-smokers	who	had	any	experience	of	vaping	more	than	tripled	
among	e-cigarette	users	compared	to	those	with	no	vaping	experience.		
	
Double	standards	on	gateway	and	“reverse”	gateway	effects?	
	
E-cigarette	enthusiasts	often	argue	that	vaping	is	demonstrably	a	reverse	gateway	out	of	
smoking	for	those	who	quit,	while	being	scathing	about	suggestions	that	it	could	ever	be	a	
gateway	into	smoking.		
	
Soundbites	like	“kids	who	will	try	stuff,	will	try	stuff”	and	“kids	who	will	smoke,	will	smoke”	
have	been	repeatedly	held	aloft	like	an	omnipotent	crucifix	before	a	gateway	vampire.	
These	responses	are	voiced	as	self-evident	truisms,	with	their	circularity	being	seductive	at	
first	blush.	However,	any	cessation	researcher	offering	the	equally	trite	“smokers	who	will	
quit,	will	quit”	as	a	serious	contribution	to	understanding	the	complexity	of	transitioning	out	
of	smoking,	would	be	rightly	pilloried	for	their	primitive	understanding	of	the	complex	
trajectories	with	multi-factorial	elements	that	can	conclude	with	permanent	smoking	
cessation.	
	
There	is	a	vast	literature	on	the	efficacy	of	smoking	cessation	interventions	(to	which	Etter,		
and	other	prominent	critics	of	e-cigarette	gateway	claims,	have	often	contributed)	where	
relevant	mediating	variables	(for	example:	level	of	addiction,	self-efficacy,	levels	of	personal	
and	professional	support,	planned	v	unplanned	and		gradual	v	rapid	quit	attempts)	are	
measured,	and	then	adjusted	for	in	estimates	of	the	contribution	of	the	cessation	drug	or	
intervention.		
	
Yet	Etter	argues	that	a	common	liability	model	(“a	propensity	to	use	nicotine”	in	any	form)	
can	explain	all	the	main	claims	of	the	gateway	hypothesis.	All	we	need	to	say	about	anyone	
who	smokes	regularly	is	that	that	they	had	a	propensity	to	do	so.	If	this	hard	determinism	
was	all	that	was	needed	to	be	invoked	in	understanding	smoking	uptake,	how	then	can	we	
explain	the	dramatic	falls	in	uptake	that	have	been	seen	in	nations	which	have	robust	
tobacco	control	programs?	What	eroded	that	“propensity”?	Nicotine	liability	may	well	be	a	
predisposing	factor.	But	what	of	the	known	tractable	reinforcing	and	enabling	factors	[12]	
that	tobacco	control	has	so	successfully	identified	and	addressed	over	decades?	
	
Implausibility	of	experimental,	occasional	vaping	transitioning	to	smoking?	
	
In	criticising	studies	which	do	not	differentiate	adolescent	occasional,	experimental	vaping	
from	more	regular	vaping,	Etter	argues	that	it	is	“hardly	plausible	that	a	simple	puff	or	a	few	
puffs	on	an	e-cigarette	can	cause	subsequent	regular	smoking.”	But	of	course	every	regular	
smoker	started	with	a	“simple	puff”,	mostly	in	adolescence.	They	then	typically	progressed	
through	experimental,	then	less-than-daily	smoking	and	finally	onto	regular,	daily	smoking.	
Many	young	smokers	categorised	in	snapshot,	cross-sectional	studies	as	experimental	(“a	
few	puffs”)	or	light,	irregular	smokers	will	soon	change	their	status.	Just	as	no	young	smoker	
commences	their	smoking	career	by	smoking	a	pack	on	their	first	day,	few	if	any	adolescent	
vapers	commence	vaping	with	heavy,	daily	use.	
	
Moreover,	Etter’s	assertion	about	implausibility	ignores	an	important	body	of	evidence	
regarding	the	high	susceptibility	of	children	and	adolescents	to	the	psychotropic	and	
addictive	effects	of	nicotine.	For	example,	Fidler	et	al	[13]	and	others	[14]	have		highlighted	
that	children	only	require	a	very	minimal	exposure	to	develop	an	important	and	identified	
“sleeper	effect”:	a	vulnerability	to	smoking	after	trying	just	a	single	cigarette,	that	can	lie	
dormant	for	three	years,	or	more:		
	
“From	a	neurobiological	viewpoint,	neural	reward	pathways	might	be	changed	as	a	
consequence	of	a	single	exposure	to	nicotine,	thus	potentially	increasing	
vulnerability	to	later	smoking	uptake”	[13]	
	
Others	have	referred	to	an	established	body	of	evidence	relating	to	youth	nicotine	
exposure:		
	
“Importantly,	several	studies	support	that	a	single	drug	exposure	can	lead	to	
changes	in	synaptic	strength	that	are	associated	with	learning	and	memory.	
Ultimately,	these	cellular	changes	could	underlie	the	long-lasting	effects	of	drugs”	
[14]		
	
The	high	susceptibility	of	children	and	youth	to	the	“neurobiological	insult”	of	nicotine	was	
recently	been	highlighted	in	the	US	Surgeon	General’s	report	on	the	potential	risks	of	
nicotine	and	electronic	cigarettes	to	youth	[15].	The	implications	of	this	material	appear	to	
escape	Etter’s	analysis	entirely.					
	
McNeill,	who	has	been	persistently	critical	of	gateway	effects	[4,	16]	authored	two	heavily	
cited	papers	which	noted	that		
	
“The first symptoms of nicotine dependence can appear within days to weeks of the 
onset of occasional use, often before the onset of daily smoking” [17].  
 
Moreover, in a 30 month follow-up of the same subjects, it was noted that  
 
“Symptoms of tobacco dependence commonly develop rapidly after the onset of 
intermittent smoking, although individuals differ widely in this regard. …There does 
not appear to be a minimum nicotine dose or duration of use as a prerequisite for 
symptoms to appear. The development of a single symptom strongly predicted 
continued use, supporting the theory that the loss of autonomy over tobacco use 
begins with the first symptom of dependence” (our emphasis) [18]. 	
 
The clear contrast between the well-established understanding of cigarette smokers' rapid 
onset of symptoms of nicotine dependence with efforts to trivialise concerns about initial 
infrequent use of e-cigarettes is therefore noteworthy. 
Schneider	and	Diehl	in	their	e-cigarettes	as	“catalysts”	model	[19],	reviewed	features	of	
vaping	that	make	it	both	attractive	to	adolescents	(perceived	lower	health	risks,	attractive	
tastes,	lower	price,	inconspicuous	use,	higher	acceptance	among	peers	and	others)	and	why	
“increasing	familiarity	with	nicotine	could	lead	to	…potential	transition	to	tobacco	smoking”.	
	
They	offer	several	cogent	and	highly	plausible	reasons	for	such	transition	that	Etter	does	not	
consider.	These	include:	
	
Accessibility:	E-cigarettes	and	cigarettes	are	often	sold	alongside	one	another.	Adolescents	
who	might	otherwise	never	visit	a	tobacco	retailer	and	be	exposed	to	retail	promotions,	
discount	offers	and	curiosity	push	cues	would	be	thus	now	exposed.	
	
Experience:	As	they	state	“Becoming	used	to	the	habitual	and	ritual	procedures	
of	smoking	such	as	poise,	handling,	smoke	breaks	and	body	language”	may	erode	negative	
feelings	about	smoking	in	some	adolescents	and	facilitate	experimentation	with	cigarettes.  
 
Finally,	despite	high	profile	claims	from	transnational	tobacco	companies	that	they	hope	to	
transition	as	many	smokers	as	possible	from	smoking	to	vaping,	an	obvious	alternative	and	
highly	plausible	business	model	for	these	companies	would	be	to	facilitate	dual	use:	
smoking	as	well	as	vaping,	rather	than	smoking	instead	of	smoking.	With	smoking	not	
allowed	in	many	locations	where	smokers	spend	many	hours	every	week,	it	would	be	very	
much	in	the	commercial	interests	of	the	industry	to	promote	both	forms	of	consumption.	
	
Strategies	like	retail	placement	of	cigarettes	with	e-cigarettes,	retailer	incentive	promotions	
to	encourage	dual	use,	cross-branding,	and	promotional	activity	in	poorly	regulated	
environments	(especially	the	internet)	promoting	messages	like	“when	you	can’t	smoke,	
vape”	seem	likely	to	follow	similar	parallel	campaigns	used	to	promote	smokeless	tobacco	
(see	Figures)	
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